Sowell Financial Services LLC Sells 14,847 Shares of CVS Health Corporation (NYSE:CVS)

Sowell Financial Services LLC decreased its holdings in CVS Health Corporation (NYSE:CVS - Free Report) by 38.7% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 23,523 shares of the pharmacy operator's stock after selling 14,847 shares during the period. Sowell Financial Services LLC's holdings in CVS Health were worth $1,594,000 as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in the business. Hopwood Financial Services Inc. purchased a new stake in shares of CVS Health during the fourth quarter valued at approximately $29,000. McIlrath & Eck LLC grew its holdings in CVS Health by 32.6% in the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock worth $32,000 after acquiring an additional 174 shares during the last quarter. Financial Perspectives Inc increased its position in shares of CVS Health by 137.5% in the fourth quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator's stock valued at $36,000 after acquiring an additional 466 shares during the period. Compass Planning Associates Inc bought a new position in shares of CVS Health during the fourth quarter valued at about $37,000. Finally, Providence First Trust Co purchased a new stake in shares of CVS Health during the fourth quarter worth about $42,000. Hedge funds and other institutional investors own 80.66% of the company's stock.

CVS Health Stock Down 0.3%

CVS Health stock traded down $0.19 during mid-day trading on Thursday, reaching $66.91. The stock had a trading volume of 5,208,935 shares, compared to its average volume of 10,943,569. The company has a market capitalization of $84.64 billion, a price-to-earnings ratio of 15.97, a PEG ratio of 0.96 and a beta of 0.56. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.82 and a quick ratio of 0.63. The company has a 50-day moving average price of $65.02 and a two-hundred day moving average price of $60.30. CVS Health Corporation has a one year low of $43.56 and a one year high of $72.51.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, topping analysts' consensus estimates of $1.62 by $0.63. The firm had revenue of $94.59 billion during the quarter, compared to analyst estimates of $93.07 billion. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The business's revenue for the quarter was up 7.0% on a year-over-year basis. During the same period in the previous year, the business posted $1.31 earnings per share. On average, analysts expect that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

Insider Buying and Selling

In other CVS Health news, Director Guy P. Sansone purchased 1,570 shares of the firm's stock in a transaction on Thursday, June 5th. The shares were acquired at an average cost of $63.70 per share, with a total value of $100,009.00. Following the completion of the acquisition, the director now directly owns 12,007 shares in the company, valued at $764,845.90. The trade was a 15.04% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. 1.22% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of research analysts recently issued reports on CVS shares. Morgan Stanley restated an "overweight" rating on shares of CVS Health in a report on Tuesday, April 15th. Mizuho upped their target price on CVS Health from $70.00 to $76.00 and gave the company an "outperform" rating in a report on Wednesday, April 9th. Royal Bank Of Canada raised their price target on CVS Health from $74.00 to $81.00 and gave the stock an "outperform" rating in a research note on Monday, May 5th. Robert W. Baird boosted their price objective on shares of CVS Health from $51.00 to $71.00 and gave the company a "neutral" rating in a research report on Tuesday, April 15th. Finally, UBS Group upped their price objective on shares of CVS Health from $67.00 to $71.00 and gave the stock a "neutral" rating in a report on Friday, May 2nd. Two research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $74.75.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.